These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8826824)

  • 1. Primary lymphoma of central nervous system in immunocompetent patients in south-east Scotland.
    Yau YH; O'Sullivan MG; Signorini D; Ironside JW; Whittle IR
    Lancet; 1996 Sep; 348(9031):890. PubMed ID: 8826824
    [No Abstract]   [Full Text] [Related]  

  • 2. Histopathology, pathogenesis and molecular genetics in primary central nervous system lymphomas.
    Nakamura M; Shimada K; Ishida E; Konishi N
    Histol Histopathol; 2004 Jan; 19(1):211-9. PubMed ID: 14702189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.
    Olson JE; Janney CA; Rao RD; Cerhan JR; Kurtin PJ; Schiff D; Kaplan RS; O'Neill BP
    Cancer; 2002 Oct; 95(7):1504-10. PubMed ID: 12237919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing incidence of CNS primary lymphoma in south-east Scotland.
    O'Sullivan MG; Whittle IR; Gregor A; Ironside JW
    Lancet; 1991 Oct; 338(8771):895-6. PubMed ID: 1681258
    [No Abstract]   [Full Text] [Related]  

  • 5. StatBite: Lymphoma incidence in HIV patients vs. general population.
    J Natl Cancer Inst; 2010 Jul; 102(14):1003. PubMed ID: 20616355
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiology of primary CNS lymphoma.
    Schabet M
    J Neurooncol; 1999 Jul; 43(3):199-201. PubMed ID: 10563423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and Prognosis.
    Lukas RV; Stupp R; Gondi V; Raizer JJ
    Oncology (Williston Park); 2018 Jan; 32(1):17-22. PubMed ID: 29447417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusely infiltrating central nervous system lymphoma involving the brainstem in an immune-competent patient.
    Alsherbini K; Beinlich B; Salamat MS
    JAMA Neurol; 2014 Jan; 71(1):110-1. PubMed ID: 24217110
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune conditions and primary central nervous system lymphoma risk among older adults.
    Mahale P; Herr MM; Engels EA; Pfeiffer RM; Shiels MS
    Br J Haematol; 2020 Feb; 188(4):516-521. PubMed ID: 31625136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphoma.
    Thorer H; Zimmermann M; Makarova O; Oschlies I; Klapper W; Lang P; von Stackelberg A; Fleischhack G; Worch J; Juergens H; Woessmann W; Reiter A; Burkhardt B
    Haematologica; 2014 Nov; 99(11):e238-41. PubMed ID: 25107886
    [No Abstract]   [Full Text] [Related]  

  • 12. Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan.
    Makino K; Nakamura H; Kino T; Takeshima H; Kuratsu J
    Surg Neurol; 2006 Nov; 66(5):503-6. PubMed ID: 17084198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary central nervous system lymphoma: immunohistochemical profile and prognostic significance.
    Raoux D; Duband S; Forest F; Trombert B; Chambonnière ML; Dumollard JM; Khaddage A; Gentil-Perret A; Péoc'h M
    Neuropathology; 2010 Jun; 30(3):232-40. PubMed ID: 19925562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on primary central nervous system lymphoma.
    Iwamoto FM; DeAngelis LM
    Hematol Oncol Clin North Am; 2006 Dec; 20(6):1267-85. PubMed ID: 17113462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary malignant non-Hodgkin's lymphomas of the central nervous system in immunocompetent patients: diagnostic, prognostic and therapeutic criteria].
    Ferracini R
    Pathologica; 1997 Apr; 89(2):146-54. PubMed ID: 9411361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of AIDS-related lymphomas.
    Sparano JA
    Curr Opin Oncol; 1995 Sep; 7(5):442-9. PubMed ID: 8541390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary non-Hodgkin's malignant lymphoma of the central nervous system].
    Monjour A; Poisson M; Kujas M; Delattre JY
    Rev Neurol (Paris); 1992; 148(10):589-600. PubMed ID: 1295053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas.
    D'Haene N; Catteau X; Maris C; Martin B; Salmon I; Decaestecker C
    Br J Haematol; 2008 Feb; 140(4):402-10. PubMed ID: 18081894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
    Chaturvedi AK; Mbulaiteye SM; Engels EA
    Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary central nervous system lymphoma: current state of anti-CD20 therapy and appraisal of reported response criteria.
    Siegal T
    J Clin Neurosci; 2014 May; 21(5):709-15. PubMed ID: 24725453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.